All In Biotech

Drug Trial Radar · NCT02474589

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat

An Expanded Double-Blind, Placebo Controlled, Multicenter Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti Orthopoxvirus Compound Tecovirimat When Administered Orally for 14 Days in Subjects

Last checked: Nov 19, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 449 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

449

Actual

Start

Jun 19, 2015

Primary completion

Aug 24, 2016

Study completion Aug 24, 2016

Sponsor

Lead sponsor
SIGA TechnologiesIndustry
Sponsor type
Industry
Collaborators
Biomedical Advanced Research and Development Authority
First posted
Jun 18, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Multicenter, double-blind, placebo controlled, Phase 3 study to determine the safety and tolerability of oral tecovirimat, an anti orthopoxvirus compound, in subjects.

Conditions

  • Smallpox

Interventions

  • tecovirimatDrug

    Study is based on Animal Regulatory Rule

  • PlaceboOther

    Does not apply

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To Determine the Number of Participants With Adverse EventsTime frame: 45 days

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Coastal Clinical Research, Inc.

    Mobile, Alabama

  • Paradigm Research

    Redding, California

  • Paradigm Research

    San Diego, California

  • Johnson County Clinical Trials

    Lenexa, Kansas

  • Heartland Research Associates, LLC

    Newton, Kansas

  • Center for Pharmaceutical Research

    Kansas City, Missouri

  • Sundance Clinical Research LLC

    St Louis, Missouri

  • Meridien Clinical Research

    Omaha, Nebraska

  • Medical Research South

    Charleston, South Carolina

  • Benchmark Research

    Austin, Texas

  • Benchmark Research

    Fort Worth, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.